Truist Financial’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-53,638	Closed	-$347K	–	2562
2023 Q2	$347K	Sell	53,638 -15,901	-23%	-$103K	﹤0.01%	2159
2023 Q1	$524K	Buy	69,539 +17,996	+35%	+$136K	﹤0.01%	1942
2022 Q4	$522K	Buy	+51,543	New	+$522K	﹤0.01%	1920